PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After SurgeryBusiness Wire • 08/12/25
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/12/25
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?The Motley Fool • 08/12/25
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost SupplyBenzinga • 08/11/25
Trump Tweets Trigger Stock Swings For Tesla, Boeing, Pfizer—And An Insider Trading InquiryBenzinga • 08/06/25
Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy BattleSeeking Alpha • 08/05/25
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line GrowthZacks Investment Research • 08/05/25